Not Signed In - Genta Cites Publication Of Study Showing Improved Outcomes In CLL Patients Treated With Genasense(R) Plus Chemotherapy
Thu, 15 Feb 2007 08:00 AM EST
... Genta Incorporated (Nasdaq: GNTA) today announced the publication of findings from a Phase 3 trial of the Company's lead anticancer drug, Genasense(R) (oblimersen sodium) Injection, when used in combination with chemotherapy for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). [click link for full article] ...
Related Topics
- Publications & Software
- Chemotherapy
- Online Publications
- Publication Request
- Side effects of chemotherapy (depending on the type of chemotherapy)
- Confusion and changes in mental status may develop if the condition is not treated.
- Fatigue and shortness of breath (if poor heart function isn't treated)
- Cll
- Fluorouracil
- Chronic lymphocytic leukemia (CLL)
- Laboratory Biosafety Publication
- Publication Lists And Catalogs
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Radiation Studies
- Nausea And Vomiting
- Side effects of chemotherapy
email this page
print this page
bookmark this page
feedback on this page
